You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 62 No. 8, August 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (77)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Psychiatry, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Somatization Increases Medical Utilization and Costs Independent of Psychiatric and Medical Comorbidity

Arthur J. Barsky, MD; E. John Orav, PhD; David W. Bates, MD

Arch Gen Psychiatry. 2005;62:903-910.

Context  Somatoform disorders are an important determinant of medical care utilization, but their independent effect on utilization is difficult to determine because somatizing patients frequently have psychiatric and medical comorbidity.

Objectives  To assess the extent of the overlap of somatization with other psychiatric disorders; to compare the medical utilization of somatizing and nonsomatizing patients; and to determine the independent contribution of somatization alone to utilization.

Design  Patients were surveyed with self-report questionnaires assessing somatization and psychiatric disorder. Medical care utilization was obtained from automated encounter data for the year preceding the index visit. Medical morbidity was indexed with a computerized medical record audit.

Setting  Two hospital-affiliated primary care practices.

Participants  Consecutive adults making scheduled visits to their primary care physicians on randomly chosen days. In all, 2668 questionnaires were distributed, and 1914 (71.7%) were returned. Of these, 1546 (80.8%) contained complete data and met eligibility criteria.

Main Outcome Measures  Medical care utilization and costs within our hospital system in the preceding 12 months.

Results  Two hundred ninety-nine patients (20.5%) received a provisional diagnosis of somatization; 42.3% of these patients had no comorbid depressive or anxiety disorder. Somatizing patients, when compared with nonsomatizing patients, had more primary care visits (mean [SE], 4.90 [0.32] vs 3.43 [0.11]; P<.001); more specialty visits (mean [SE], 8.13 [0.55] vs 4.90 [0.21]; P<.001); more emergency department visits (mean [SE], 1.29 [0.15] vs 0.52 [0.036]; P<.001); more hospital admissions (mean [SE], 0.32 [0.051] vs 0.13 [0.014]; P<.001); higher inpatient costs (mean [SE], $3146 [$380] vs $991 [$193]; P<.001); and higher outpatient costs (mean [SE], $3208 [$180] vs $1771 [$91]; P<.001). When these results were adjusted for the presence of comorbid anxiety and depressive disorders, major medical morbidity, and sociodemographic characteristics, patients with somatoform disorder still had more primary care visits (P = .04), more specialist visits (P = .002), more emergency department visits (P<.001), more hospital admissions (P<.001), more ambulatory procedures (P<.001), higher inpatient costs (P<.001), and higher outpatient costs (P<.001). When these findings are extrapolated to the national level, an estimated $256 billion a year in medical care costs are attributable to the incremental effect of somatization alone.

Conclusions  Patients with somatization had approximately twice the outpatient and inpatient medical care utilization and twice the annual medical care costs of nonsomatizing patients. Adjusting the findings for the presence of psychiatric and medical comorbidity had relatively little effect on this association.


Author Affiliations: Department of Psychiatry (Dr Barsky) and Division of General Internal Medicine, Department of Medicine (Drs Orav and Bates), Brigham and Women’s Hospital and Harvard Medical School, and Department of Health Care Policy, Harvard School of Public Health (Dr Bates), Boston, Mass.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Review: Use of Electronic Medical Records for Health Outcomes Research: A Literature Review
Dean et al.
Med Care Res Rev 2009;66:611-638.
ABSTRACT  

Intelligence is negatively associated with the number of functional somatic symptoms
Kingma et al.
J. Epidemiol. Community Health 2009;63:900-905.
ABSTRACT | FULL TEXT  

Efficacy of Treatment for Somatoform Disorders: A Review of Randomized Controlled Trials
Kroenke
Focus 2009;7:414-423.
ABSTRACT | FULL TEXT  

Posttraumatic Stress and Somatization in Abused Women
Samelius et al.
Traumatology 2009;15:103-112.
ABSTRACT  

Determinants of symptoms in functional dyspepsia: gastric sensorimotor function, psychosocial factors or somatisation?
Van Oudenhove et al.
Gut 2008;57:1666-1673.
ABSTRACT | FULL TEXT  

Cognitive-behavioural therapy for health anxiety in a genitourinary medicine clinic: randomised controlled trial
Seivewright et al.
Br. J. Psychiatry 2008;193:332-337.
ABSTRACT | FULL TEXT  

Alexithymia and Somatization in General Population
Mattila et al.
Psychosom. Med. 2008;70:716-722.
ABSTRACT | FULL TEXT  

Assessment and management of medically unexplained symptoms
Hatcher and Arroll
BMJ 2008;336:1124-1128.
FULL TEXT  

Prevalence, Impact, and Prognosis of Multisomatoform Disorder in Primary Care: A 5-Year Follow-up Study
Jackson and Kroenke
Psychosom. Med. 2008;70:430-434.
ABSTRACT | FULL TEXT  

Cluster randomised controlled trial of training practices in reattribution for medically unexplained symptoms
Morriss et al.
Br. J. Psychiatry 2007;191:536-542.
ABSTRACT | FULL TEXT  

Stability of Somatoform Symptoms Implications for Classification
Rief and Rojas
Psychosom. Med. 2007;69:864-869.
ABSTRACT | FULL TEXT  

Somatoform and Substance Use Disorders
Hasin and Katz
Psychosom. Med. 2007;69:870-875.
ABSTRACT | FULL TEXT  

Efficacy of Treatment for Somatoform Disorders: A Review of Randomized Controlled Trials
Kroenke
Psychosom. Med. 2007;69:881-888.
ABSTRACT | FULL TEXT  

Primary Care Consultations About Medically Unexplained Symptoms: Patient Presentations and Doctor Responses That Influence the Probability of Somatic Intervention
Salmon et al.
Psychosom. Med. 2007;69:571-577.
ABSTRACT | FULL TEXT  

Physical and Mental Comorbidity, Disability, and Suicidal Behavior Associated With Posttraumatic Stress Disorder in a Large Community Sample
Sareen et al.
Psychosom. Med. 2007;69:242-248.
ABSTRACT | FULL TEXT  

Anxiety Disorders in Primary Care: Prevalence, Impairment, Comorbidity, and Detection
Kroenke et al.
ANN INTERN MED 2007;146:317-325.
ABSTRACT | FULL TEXT  

Disability and poor quality of life associated with comorbid anxiety disorders and physical conditions.
Sareen et al.
Arch Intern Med 2006;166:2109-2116.
ABSTRACT | FULL TEXT  

Disposition of emergency department patients with psychiatric comorbidity: results from the 2004 National Hospital Ambulatory Medical Care Survey.
Kunen et al.
Emerg. Med. J. 2006;23:274-275.
ABSTRACT | FULL TEXT  

Frequent Flyers? Look for Somatization
JWatch Psychiatry 2005;2005:12-12.
FULL TEXT  

Frequent Flyers? Look for Somatization
JWatch Women's Health 2005;2005:9-9.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.